General changes in hemostasis in gastric cancer

Bratislava Medical Journal

Volumn 110, Issue 4, 2009, Pages 215-221

  Kovacova, E ^a   Kinova, S ^a   Duris, I ^a   Remkova, A ^a  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

Author keywords

Fibrinolytic system; Gastric cancer; Primary hemostasis; Thromboembolism

Indexed keywords

BLOOD CLOTTING INHIBITOR; THROMBOCYTE ACTIVATING FACTOR;

ADULT; AGED; ARTICLE; BLOOD; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; MALE; MIDDLE AGED; PARANEOPLASTIC SYNDROME; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; STOMACH TUMOR; THROMBOCYTE COUNT;

ADULT; AGED; BLOOD COAGULATION FACTOR INHIBITORS; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; PARTIAL THROMBOPLASTIN TIME; PLATELET ACTIVATING FACTOR; PLATELET COUNT; PROTHROMBIN TIME; STOMACH NEOPLASMS;

EID: 84872136667     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Nand S, Messmore H. Hemostasis in malignancy. Amer J Hematol 1991; 38 (4): 337-338.
2. Gouin-Thibault I, Samama MM. Laboratory diagnosis of the throm-bophilic state in cancer patients. Semin Thromb Hemost 1999; 25 (2): 167-172.
3. Aliustaoglu M, Yumuk PF, Gumus M, Ekenel M, Bolukbas F, Bolukbas C, Mutlu N, Basaran G, Avsar E, Turhal NS. D-dimer-can it be a marker for malignant gastric lesions? Acta Oncol 2004; 43 (8): 770-771.
4. Kurabayashi T, Isii K, Suzuki M, Takakuwa K, Shibazaki Y, Ozawa T, Narisawa R, Sekizuka N, Tanaka K. Advanced gastric can cer and a concomitant pregnancy associated with disseminated intra-vascular coagulation. Amer J Perinatol 2004; 21 (5): 295-298.
5. Bajaj MS, Kuppuswamy MN, Siato H, Spitzer SG, Bajaj SP. Cul tured normal hepatocytes do not synthesize lipoprotein-associated coa gulation inhibitor: evidence that endothelium is the principal site of its synthesis. Proc Natl Acad Sci 1990; 87: 8869-8873.
6. Silverberg JM, Gordon S, Zucker S. Identification of tissue factor in two pancreatic cancer cell lines. Cancer Res 1989; 49: 5443-5447.
7. Remkova A, Kovacova E, Prikazska M, Kratochvilova H. Throm-bomodulin as a marker of endothelium demage in some clinical condi tions. EJ Internal Med 2000; 11 (2): 79-84.
8. Hamatake M, Ishida T, Mitsudomi T, Akazawa K, Sugimachi K. Prognostic value and clinicopathological correlation of thrombomodu-lin in squamous cell carcinoma of the human lung. Clin Cancer Res 1996; 2: 763-766.
9. Rickles FR, Levine MN, Edwards RI. Hemostatic alterations in cancer patients. Cancer Metast Rev 1992; 11 (3-4): 237-248.
10. Karpatkin S, Nierodzik ML, Klepfish A. Role of plate-lets and thrombin in cancer. Vessels 1996; 2 (4): 17-30.
11. Verheul HM, Hoekman K, Luykx de Bakker, S Eekman CA, Folman CC. Platelet: transporter of vascular endothelial growth factor. Clin Cancer Res 1997; 3 (12ptl): 2187-2190.
12. Francis JL, Biggerstaff J, Amirkhosravi A. Hemostasis and ma lignancy. Semin Thromb Hemost 1998; 24 (2): 93-109.
13. Kovacova E, Okrucka A, Kratochvil'ova H. Stanovenie antitrom-binu II v klinickej praxi. Slovensko-ceska konferencia o tromboze a hemostaze Martin, 1996, Abstr, p 19.
14. Hromec A, Okrucka A, Duris I. Zmeny hemostazy a hemokoagu-lacie pri vredovej chorobe gastroduodena a pri malignomoch traviace-ho traktu komplikovanych krvacanim. Bratisl Lek Listy 1986; 85 (2): 209-219.
15. Okrucka A. Zmeny hemostazy pri malignych ochoreniach. Folia Facultatis Medicae 1991; 29 (2): 9-67.
16. Prandoni P, Falanga A, Piccioli A. Cancer and venous thrombo-embolism. The Lancet Oncology 2005; 6 (6): 401-410.
17. Prandoni P, Trujillo-Santos J, Surico T, Dalla Valle F, Piccioli A, Monreal M. Recurrent thromboembolism and major bleeding du ring oral anticoagulant therapy in patients with solid cancer: findings from the RIETE registry. Haematologica 2008; 93 (9): 1432-1434.
18. Prins MH, Lensing AWA, Hirs J. Idiopathic deep venous throm bosis. Is a search for malignant disease justified. Arg Intern Med 1994; 154: 1310-1315.
19. Oefelein MG, Brant M, Crotty K. Idiopathic thrombo-embolism as the presenting sign of occult prostate cancer. Urology 1998; 51 (5): 775-780.
20. Kakkar AK, de Lorenzo F, Pineo GF, Williamson RC. Venous thromboembolism and cancer. Baillieres Clin Haematol 1998; 11 (3): 675-687.
21. Zacharski LR, Prandoni P, Monreal M. Warfarin versus low-molecular-weight heparin therapy in cancer patients. Oncologist 2005; 10 (1): 72-79.
22. Adess M, Eisner R, Nand S, Godwin J, Messmore HL Jr, Wehr-macher WH. Thromboembolism in cancer patients: pathogenesis and treatment. Clin Appl Thromb Hemost 2006; 12 (3): 254-266.